Serving High-Quality Pharmaceutical Medicines

Call Us Now:

022-27783600

Mailing Address:

sales@livealthbiopharma.in

Aeo1
Star-export-house

Research & Development

Research & Development: Innovating for a Healthier Tomorrow

At Livealth Biopharma, we believe that the future of healthcare lies in continuous innovation. We have established a state-of-art Research and Development Centre (R&D) – focused towards developing new products, improving existing products as well as drug delivery systems and expanding product applications. Livealth Biopharma has a team of experienced scientists specializing in Formulation Development, Analytical development and Conducting Stability Studies. Our Research & Development (R&D) division is the cornerstone of our mission to deliver cutting-edge pharmaceutical solutions that address the evolving needs of patients and healthcare providers worldwide.

With a presence in 45+ countries for commercial supply and products registered in 28 countries, our dedicated research team is committed to developing a range of formulations and products as per customer specifications and for positively impacting health and wellbeing.

The Centre supports design and register formulations in its various markets, detailed study and documentation is generated with the help of the regulatory department for various country specific registrations for ROW Countries.

Our R&D capabilities include

Our R&D efforts are driven by a simple yet powerful vision: to develop safe, effective, and accessible pharmaceutical products that make a meaningful difference in global health. We focus on: 

Research & Development
Strategy

Our strategy focuses on

Our R&D efforts are driven by a simple yet powerful vision: to develop safe, effective, and accessible pharmaceutical products that make a meaningful difference in global health. We focus on: 

Our Impact

Through our R&D efforts, we have developed a robust portfolio of pharmaceutical products that are trusted by healthcare professionals and patients in 28 countries and counting. Our innovations have not only improved treatment outcomes but have also expanded access to essential medicines in underserved regions.